BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18381422)

  • 1. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
    Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW
    Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
    Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
    Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization.
    Bainer RO; Veneris JT; Yamada SD; Montag A; Lingen MW; Gilad Y; Rinker-Schaeffer CW
    Clin Exp Metastasis; 2012 Jun; 29(5):397-408. PubMed ID: 22350525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells.
    Taylor JL; Szmulewitz RZ; Lotan T; Hickson J; Griend DV; Yamada SD; Macleod K; Rinker-Schaeffer CW
    Cancer Lett; 2008 Dec; 272(1):12-22. PubMed ID: 18572308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
    Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW
    Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines.
    Robinson VL; Shalhav O; Otto K; Kawai T; Gorospe M; Rinker-Schaeffer CW
    Mol Cancer Res; 2008 Mar; 6(3):501-8. PubMed ID: 18337456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
    Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
    Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression.
    Szmulewitz RZ; Clark R; Lotan T; Otto K; Taylor Veneris J; Macleod K; Rinker-Schaeffer C
    Int J Cancer; 2012 Feb; 130(3):509-20. PubMed ID: 21351092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.
    Spillman MA; Lacy J; Murphy SK; Whitaker RS; Grace L; Teaberry V; Marks JR; Berchuck A
    Gynecol Oncol; 2007 May; 105(2):312-20. PubMed ID: 17276500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Int J Cancer; 2011 Jan; 128(1):94-104. PubMed ID: 20309881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MKK4 acts as a potential tumor suppressor in ovarian cancer.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Tumour Biol; 2011 Aug; 32(4):661-70. PubMed ID: 21487811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed cell cycle progression in selenoprotein W-depleted cells is regulated by a mitogen-activated protein kinase kinase 4-p38/c-Jun NH2-terminal kinase-p53 pathway.
    Hawkes WC; Alkan Z
    J Biol Chem; 2012 Aug; 287(33):27371-9. PubMed ID: 22730327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
    Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
    Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
    Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
    Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
    Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MKK4 Inhibitors-Recent Development Status and Therapeutic Potential.
    Katzengruber L; Sander P; Laufer S
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
    Yoshida BA; Dubauskas Z; Chekmareva MA; Christiano TR; Stadler WM; Rinker-Schaeffer CW
    Cancer Res; 1999 Nov; 59(21):5483-7. PubMed ID: 10554023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
    Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
    J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth.
    Liu W; Zi M; Jin J; Prehar S; Oceandy D; Kimura TE; Lei M; Neyses L; Weston AH; Cartwright EJ; Wang X
    Circ Res; 2009 Apr; 104(7):905-14. PubMed ID: 19265040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.